A detailed history of State Street Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 11,816,249 shares of VRTX stock, worth $4.79 Billion. This represents 0.23% of its overall portfolio holdings.

Number of Shares
11,816,249
Previous 11,726,076 0.77%
Holding current value
$4.79 Billion
Previous $5.5 Billion 0.01%
% of portfolio
0.23%
Previous 0.24%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$460.0 - $505.78 $41.5 Million - $45.6 Million
90,173 Added 0.77%
11,816,249 $5.5 Billion
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $110 Million - $136 Million
-280,407 Reduced 2.34%
11,726,076 $5.5 Billion
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $31.5 Million - $34.5 Million
-77,335 Reduced 0.64%
12,006,483 $5.02 Billion
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $15.2 Million - $18.2 Million
44,272 Added 0.37%
12,083,818 $4.92 Billion
Q3 2023

Nov 14, 2023

SELL
$338.18 - $362.46 $98.8 Million - $106 Million
-292,047 Reduced 2.37%
12,039,546 $4.19 Billion
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $39 Million - $43.7 Million
124,141 Added 1.02%
12,331,593 $4.34 Billion
Q1 2023

May 15, 2023

SELL
$283.23 - $323.1 $46.2 Million - $52.7 Million
-162,978 Reduced 1.32%
12,207,452 $3.85 Billion
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $21.6 Million - $24.3 Million
75,639 Added 0.62%
12,370,430 $3.57 Billion
Q3 2022

Nov 15, 2022

BUY
$273.83 - $305.53 $8.42 Million - $9.39 Million
30,742 Added 0.25%
12,294,791 $3.56 Billion
Q2 2022

Aug 15, 2022

BUY
$234.96 - $292.55 $49.6 Million - $61.8 Million
211,286 Added 1.75%
12,264,049 $3.46 Billion
Q1 2022

May 16, 2022

SELL
$221.42 - $260.97 $67.3 Million - $79.4 Million
-304,152 Reduced 2.46%
12,052,763 $3.15 Billion
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $5.93 Million - $7.49 Million
33,499 Added 0.27%
12,356,915 $2.71 Billion
Q3 2021

Nov 15, 2021

BUY
$181.39 - $202.99 $112 Million - $125 Million
617,593 Added 5.28%
12,323,416 $2.24 Billion
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $99.5 Million - $117 Million
530,785 Added 4.75%
11,705,823 $2.36 Billion
Q1 2021

May 17, 2021

SELL
$207.02 - $241.31 $54 Million - $63 Million
-261,026 Reduced 2.28%
11,175,038 $2.4 Billion
Q4 2020

Feb 16, 2021

BUY
$207.01 - $276.09 $15.3 Million - $20.5 Million
74,118 Added 0.65%
11,436,064 $2.7 Billion
Q3 2020

Nov 10, 2020

SELL
$255.65 - $303.1 $78.3 Million - $92.8 Million
-306,299 Reduced 2.63%
11,361,946 $3.09 Billion
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $49.4 Million - $64.8 Million
219,002 Added 1.91%
11,668,245 $3.39 Billion
Q1 2020

May 11, 2020

BUY
$199.77 - $247.81 $2.29 Billion - $2.84 Billion
11,449,243 New
11,449,243 $2.72 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $104B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.